Rapid Micro Biosystems, Inc. has filed an 8-K report detailing the departure of its Chief Operating Officer, John Wilson, effective April 10, 2026. This decision comes as Mr. Wilson seeks to spend more time with his family and is not attributed to any disagreements regarding the company's operations or policies. In light of this transition, Robert Spignesi, the current President and CEO, will also take on the role of principal operating officer starting on the same date. The company has entered into a Consulting Services and Separation Agreement with Mr. Wilson, which includes a general release of claims, separation benefits, and provisions for advisory services at a rate of $200 per hour, capped at 20 hours per month until June 30, 2026. This agreement also extends the post-termination exercise period for Mr. Wilson's vested stock options until March 31, 2027. The leadership change is expected to have a small negative impact on the company's operations as it adjusts to the new structure, but no immediate adverse effects on liquidity or governance are anticipated.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.